Katarzyna Targowska-Duda - Publications

Affiliations: 
Department of Biopharmacy Medical University of Lublin 

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Targowska-Duda KM, Maj M, Drączkowski P, Budzyńska B, Boguszewska-Czubara A, Wróbel TM, Laitinen T, Kaczmar P, Poso A, Kaczor AA. WaterMap-Guided Structure-Based Virtual Screening for Acetylcholinesterase Inhibitors. Chemmedchem. 17: e202100721. PMID 35157366 DOI: 10.1002/cmdc.202100721  0.723
2021 Targowska-Duda KM, Budzynska B, Michalak A, Wnorowski A, Loland CJ, Maj M, Manetti D, Romanelli MN, Jozwiak K, Biala G, Arias HR. Type I and type II positive allosteric modulators of α7 nicotinic acetylcholine receptors induce antidepressant-like activity in mice by a mechanism involving receptor potentiation but not neurotransmitter reuptake inhibition. Correlation with mTOR intracellular pathway activation. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 52: 31-47. PMID 34237657 DOI: 10.1016/j.euroneuro.2021.06.006  0.629
2020 Zakrocka I, Targowska-Duda K, Wnorowski A, Kocki T, Jóźwiak K, Turski W, Załuska W. P0016Effect Of Gemfibrozil On Kynurenine Aminotransferase Activity And Kynurenic Acid Production In Rat Kidney Nephrology Dialysis Transplantation. 35. DOI: 10.1093/Ndt/Gfaa142.P0016  0.675
2019 Targowska-Duda KM, Budzynska B, Michalak A, Jozwiak K, Biala G, Arias HR. 3-Furan-2-yl-N-p-tolyl-acrylamide, a highly selective positive allosteric modulator of α7 nicotinic receptors, produces anxiolytic-like activity in mice. Journal of Psychopharmacology (Oxford, England). 269881118821100. PMID 30644335 DOI: 10.1177/0269881118821100  0.627
2019 Zakrocka I, Targowska-Duda KM, Wnorowski A, Kocki T, Jóźwiak K, Turski WA. Influence of Cyclooxygenase-2 Inhibitors on Kynurenic Acid Production in Rat Brain in Vitro. Neurotoxicity Research. 35: 244-254. PMID 30178287 DOI: 10.1007/S12640-018-9952-9  0.742
2019 Zakrocka I, Targowska-Duda KM, Wnorowski A, Kocki T, Jóźwiak K, Załuska W, Turski WA. FP026DICLOFENAC INHIBITS KYNURENINE AMINOTRANSFERASE ACTIVITY AND KYNURENIC ACID PRODUCTION IN RAT KIDNEY Nephrology Dialysis Transplantation. 34. DOI: 10.1093/Ndt/Gfz106.Fp026  0.67
2018 Zakrocka I, Targowska-Duda KM, Wnorowski A, Kocki T, Jóźwiak K, Turski WA. Angiotensin II type 1 receptor blockers decrease kynurenic acid production in rat kidney in vitro. Naunyn-Schmiedeberg's Archives of Pharmacology. PMID 30370429 DOI: 10.1007/S00210-018-1572-7  0.752
2018 Targowska-Duda KM, Kaczor AA, Jozwiak K, Arias HR. Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: An in silico study. Journal of Biomolecular Structure & Dynamics. 1-66. PMID 29363414 DOI: 10.1080/07391102.2018.1427634  0.617
2018 Zakrocka I, Targowska-Duda K, Wnorowski A, Kocki T, Jóźwiak K, Turski W. FP036THE INFLUENCE OF CANDESARTAN ON KYNURENIC ACID PRODUCTION IN RAT KIDNEY IN VITRO Nephrology Dialysis Transplantation. 33: i59-i59. DOI: 10.1093/Ndt/Gfy104.Fp036  0.668
2017 Zakrocka I, Targowska-Duda KM, Wnorowski A, Kocki T, Jóźwiak K, Turski WA. Angiotensin II Type 1 Receptor Blockers Inhibit KAT II Activity in the Brain-Its Possible Clinical Applications. Neurotoxicity Research. PMID 28733707 DOI: 10.1007/S12640-017-9781-2  0.741
2016 Arias HR, Ravazzini F, Targowska-Duda KM, Kaczor AA, Feuerbach D, Boffi JC, Draczkowski P, Montag D, Brown BM, Elgoyhen AB, Jozwiak K, Puia G. Positive allosteric modulators of α7 nicotinic acetylcholine receptors affect neither the function of other ligand- and voltage-gated ion channels and acetylcholinesterase, nor β-amyloid content. The International Journal of Biochemistry & Cell Biology. 76: 19-30. PMID 27129924 DOI: 10.1016/J.Biocel.2016.04.015  0.768
2016 Kaczor AA, Rutkowska E, Bartuzi D, Targowska-Duda KM, Matosiuk D, Selent J. Computational methods for studying G protein-coupled receptors (GPCRs). Methods in Cell Biology. 132: 359-99. PMID 26928552 DOI: 10.1016/Bs.Mcb.2015.11.002  0.714
2016 Targowska-Duda KM, Wnorowski A, Budzynska B, Jozwiak K, Biala G, Arias HR. The positive allosteric modulator of α7 nicotinic acetylcholine receptors, 3-furan-2-yl-N-p-tolyl-acrylamide, enhances memory processes and stimulates ERK1/2 phosphorylation in mice. Behavioural Brain Research. PMID 26778787 DOI: 10.1016/J.Bbr.2016.01.002  0.742
2015 Bagdas D, Targowska-Duda KM, López JJ, Perez EG, Arias HR, Damaj MI. The Antinociceptive and Antiinflammatory Properties of 3-furan-2-yl-N-p-tolyl-acrylamide, a Positive Allosteric Modulator of α7 Nicotinic Acetylcholine Receptors in Mice. Anesthesia and Analgesia. 121: 1369-77. PMID 26280585 DOI: 10.1213/Ane.0000000000000902  0.323
2015 Arias HR, Targowska-Duda KM, Feuerbach D, Jozwiak K. The antidepressant-like activity of nicotine, but not of 3-furan-2-yl-N-p-tolyl-acrylamide, is regulated by the nicotinic receptor β4 subunit Neurochemistry International. 87: 110-116. PMID 26116439 DOI: 10.1016/J.Neuint.2015.06.006  0.623
2015 Arias HR, Targowska-Duda KM, Feuerbach D, Jozwiak K. Coronaridine congeners inhibit human α3β4 nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites International Journal of Biochemistry and Cell Biology. 65: 81-90. PMID 26022277 DOI: 10.1016/J.Biocel.2015.05.015  0.597
2015 Arias HR, Feuerbach D, Targowska-Duda K, Kaczor AA, Poso A, Jozwiak K. Pharmacological and molecular studies on the interaction of varenicline with different nicotinic acetylcholine receptor subtypes. Potential mechanism underlying partial agonism at human α4β2 and α3β4 subtypes. Biochimica Et Biophysica Acta. 1848: 731-41. PMID 25475645 DOI: 10.1016/J.Bbamem.2014.11.003  0.69
2014 Jozwiak K, Targowska-Duda KM, Kaczor AA, Kozak J, Ligeza A, Szacon E, Wrobel TM, Budzynska B, Biala G, Fornal E, Poso A, Wainer IW, Matosiuk D. Synthesis, in vitro and in vivo studies, and molecular modeling of N-alkylated dextromethorphan derivatives as non-competitive inhibitors of α3β4 nicotinic acetylcholine receptor. Bioorganic & Medicinal Chemistry. 22: 6846-56. PMID 25464883 DOI: 10.1016/J.Bmc.2014.10.036  0.71
2014 Vázquez-Gómez E, Arias HR, Feuerbach D, Miranda-Morales M, Mihailescu S, Targowska-Duda KM, Jozwiak K, García-Colunga J. Bupropion-induced inhibition of α7 nicotinic acetylcholine receptors expressed in heterologous cells and neurons from dorsal raphe nucleus and hippocampus. European Journal of Pharmacology. 740: 103-11. PMID 25016090 DOI: 10.1016/J.Ejphar.2014.06.059  0.659
2014 Targowska-Duda KM, Feuerbach D, Biala G, Jozwiak K, Arias HR. Antidepressant activity in mice elicited by 3-furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic acetylcholine receptor. Neuroscience Letters. 569: 126-30. PMID 24708923 DOI: 10.1016/J.Neulet.2014.03.067  0.609
2014 Bondarenko V, Targowska-Duda KM, Jozwiak K, Tang P, Arias HR. Molecular interactions between mecamylamine enantiomers and the transmembrane domain of the human α4β2 nicotinic receptor. Biochemistry. 53: 908-18. PMID 24437521 DOI: 10.1021/Bi400969X  0.608
2014 Arias HR, Biala G, Kruk-Słomka MK, Targowska-Duda K. Interaction of nicotinic receptors with bupropion: Structural, functional, and pre-clinical perspectives Receptors and Clinical Investigation. 1. DOI: 10.14800/Rci.65  0.462
2013 Targowska-Duda KM, Jozwiak K, Arias HR. Role of the nicotinic receptor β4 subunit in the antidepressant activity of novel N,6-dimethyltricyclo[5.2.1.02,6]decan-2-amine enantiomers Neuroscience Letters. 553: 186-190. PMID 23994392 DOI: 10.1016/J.Neulet.2013.08.036  0.58
2012 Arias HR, Feuerbach D, Targowska-Duda KM, Aggarwal S, Lapinsky DJ, Jozwiak K. Structural and functional interaction of (±)-2-(N-tert-butylamino)-3'-iodo-4'-azidopropiophenone, a photoreactive bupropion derivative, with nicotinic acetylcholine receptors. Neurochemistry International. 61: 1433-41. PMID 23103524 DOI: 10.1016/J.Neuint.2012.10.011  0.616
2011 Arias HR, Feuerbach D, Targowska-Duda KM, Jozwiak K. Structure-activity relationship of ibogaine analogs interacting with nicotinic acetylcholine receptors in different conformational states International Journal of Biochemistry and Cell Biology. 43: 1330-1339. PMID 21642011 DOI: 10.1016/J.Biocel.2011.05.011  0.61
2010 Arias HR, Rosenberg A, Targowska-Duda KM, Feuerbach D, Yuan XJ, Jozwiak K, Moaddel R, Wainer IW. Interaction of ibogaine with human alpha3beta4-nicotinic acetylcholine receptors in different conformational states. The International Journal of Biochemistry & Cell Biology. 42: 1525-35. PMID 20684041 DOI: 10.1016/J.Biocel.2010.05.011  0.686
2010 Arias HR, Feuerbach D, Targowska-Duda KM, Russell M, Jozwiak K. Interaction of selective serotonin reuptake inhibitors with neuronal nicotinic acetylcholine receptors. Biochemistry. 49: 5734-42. PMID 20527991 DOI: 10.1021/Bi100536T  0.658
2010 Arias HR, Feuerbach D, Targowska-Duda KM, Jozwiak K. Catharanthine alkaloids are noncompetitive antagonists of muscle-type nicotinic acetylcholine receptors Neurochemistry International. 57: 153-161. PMID 20493225 DOI: 10.1016/J.Neuint.2010.05.007  0.669
2010 Arias HR, Rosenberg A, Feuerbach D, Targowska-Duda KM, Maciejewski R, Jozwiak K, Moaddel R, Glick SD, Wainer IW. Interaction of 18-methoxycoronaridine with nicotinic acetylcholine receptors in different conformational states. Biochimica Et Biophysica Acta. 1798: 1153-63. PMID 20303928 DOI: 10.1016/J.Bpj.2010.12.1704  0.704
2010 Arias HR, Rosenberg A, Targowska-Duda KM, Feuerbach D, Jozwiak K, Moaddel R, Wainer IW. Tricyclic antidepressants and mecamylamine bind to different sites in the human alpha4beta2 nicotinic receptor ion channel. The International Journal of Biochemistry & Cell Biology. 42: 1007-18. PMID 20223294 DOI: 10.1016/J.Biocel.2010.03.002  0.716
2010 Arias HR, Targowska-Duda KM, Feuerbach D, Sullivan CJ, Maciejewski R, Jozwiak K. Different interaction between tricyclic antidepressants and mecamylamine with the human α3β4 nicotinic acetylcholine receptor ion channel Neurochemistry International. 56: 642-649. PMID 20117161 DOI: 10.1016/J.Neuint.2010.01.011  0.648
2009 Arias HR, Gumilar F, Rosenberg A, Targowska-Duda KM, Feuerbach D, Jozwiak K, Moaddel R, Wainer IW, Bouzat C. Interaction of bupropion with muscle-type nicotinic acetylcholine receptors in different conformational states. Biochemistry. 48: 4506-18. PMID 19334677 DOI: 10.1021/Bi802206K  0.689
Show low-probability matches.